SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-09-002613
Filing Date
2009-10-23
Accepted
2009-10-23 17:18:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da207422005_10232009.htm SC 13D/A 197928
  Complete submission text file 0000921895-09-002613.txt   199919
Mailing Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608 510-595-6000
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (Subject) CIK: 0000918112 (see all company filings)

IRS No.: 943049219 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-49135 | Film No.: 091135155
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice